A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients

Transplantation Proceedings

Volumn 37, Issue 7, 2005, Pages 3053-3055

  Nafar, M ^a   Lessan Pezeshki, M ^b   Farrokhi, F ^b   Einollahi, B ^b   Pour Reza Gholi, F ^b   Firouzan, A ^b   Farhangi, S ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMOCYTE ANTIBODY; VIRUS ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SEROLOGY; SURGICAL INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTILYMPHOCYTE SERUM; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS;

EID: 26444482383     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.08.007     Document Type: Article

References (11)

1. R.H. Rubin Infectious disease complications of renal transplantation Kidney Int 44 1993 221
2. D.C. Brennan Cytomegalovirus in renal transplantion J Am Soc Nephrol 12 2001 848
3. E. Farrugia, T.R. Schwab Management and prevention of cytomegalovirus infection after renal transplantation Mayo Clin Proc 67 1992 879
4. S.V. Jassal, J.M. Roscoe, J.S. Zaltzman Clinical practice guidelines prevention of cytomegalovirus disease after renal transplantation J Am Soc Nephrol 9 1998 1697
5. J. Kletzmayr, E. Kreuzwieser, T. Watkins-Riedel Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients Transplantation 70 2000 1174
6. S.M. Flechner, R.K. Avery, R. Fisher A randomized prospective controlled trial of acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients Transplantation 66 1998 1682
7. D.C. Brennan, K.A. Garlock, G.G. Singer Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients Transplantation 64 1997 1843
8. A.L. Isenberg, G.K. Shen, T.P. Singh Failure of ganciclovir prophylaxis to completely eradicate CMV disease in renal transplant recipients treated with intense anti-rejection immunotherapy Clin Transplant 14 2000 193
9. M.H. Sayegh, J.P. Vella, W.M. Bennett Cytomegalovirus infection in renal transplant recipients Uptodate 11 2 2003
10. A. Humar, K.J. Gillingham, W.D. Payne Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients Transplantation 68 1999 1879
11. S. Sagedal, K.P. Nordal, A. Hartmann The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients Am J Transplant 2 2002 850